Penile Implants Market Size & Share 2024 - 2032

Penile Implants Market Size

Penile Implants Market was valued at around USD 453.1 million in 2023 and is estimated to grow at 4.7% CAGR from 2024 to 2032, due to the rising incidence of erectile dysfunction. For instance, according to the statistics, by 2025, 322 million men are expected to be affected by ED worldwide, a rise from 152 million men in 1995. As more men experience ED, there is a growing demand for effective treatment options, including penile implants. Advances in surgical techniques and penile implant technology have led to improved outcomes and reduced complication rates associated with implantation procedures.

Moreover, growing prevalence of chronic diseases, rising adoption of erectile dysfunction device, advancement in health analytics, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the spreading factors fostering the growth of the market.
 

Penile Implants Market Trends

The growing prevalence of chronic diseases is a significant driver for penile implants industry. As the global population ages, there is a corresponding increase in the prevalence of chronic diseases and age-related sexual health issues, leading to a higher incidence of ED.
 

• Erectile dysfunction is strongly associated with various diseases and conditions including prediabetes, diabetes, hypertension, cardiovascular disease, obesity, and metabolic syndrome. These conditions can lead to damage to blood vessels, nerves, and tissues in the penis, impairing erectile function and increasing the likelihood of ED development or progression.
   
• According to the World Health Organization, in 2023, the prevalence of erectile dysfunction among obese men was 64.9% and among the morbidly obese was 72.4%. As per the same report, there were significant positive relationships between erectile dysfunction and having a chronic disease.
   
• Further, according to the National Institutes of Health, in 2023, in different regions of the world, the prevalence of diabetes mellitus-induced erectile dysfunction (DMED) ranges from 35.8% to 86.1%.
   
• Chronic diseases can directly affect erectile function by causing vascular insufficiency, neuropathy, hormonal imbalances, and endothelial dysfunction, which are common underlying mechanisms of ED. Thus, leading to the growth of the market.
   

Penile Implants Market Analysis

Based on implant type, the market is segmented into inflatable and non-inflatable. The inflatable segment is estimated to reach USD 409.2 million by 2032.
 

• Inflatable penile implants offer superior functionality compared to semi-rigid or malleable implants. They allow for on-demand erections by providing the ability to inflate and deflate the device using a pump mechanism. This enables men to achieve a more natural-feeling erection that closely mimics the physiological process, enhancing sexual satisfaction for both the patient and their partner.
   
• These implants are associated with higher patient satisfaction. The ability to achieve a flaccid state by deflating the device provides greater comfort and discretion for the patient during non-sexual activities, such as urination, dressing, and physical activity. This contributes to improved quality of life and overall treatment.
   
• Moreover, modern inflatable penile implants are designed to be durable, reliable, and long-lasting. They are constructed from biocompatible materials with high mechanical strength and resistance to wear and tear, minimizing the risk of device failure or malfunction over time, thereby leading the segmental growth.

Learn more about the key segments shaping this market

Download Free PDF

Based on material, the penile implants market is divided into silicone, bioflex, other materials. The silicone segment was crossed USD 231.6 million in 2023.
 

• Silicone implants offer a balance of flexibility and durability, allowing them to withstand the mechanical stresses and movements associated with sexual activity without compromising structural integrity. This durability ensures long-term performance and reliability of the implant, minimizing the need for replacement or revision surgeries.
   
• Further, these implants are designed to have a natural feel and appearance, closely resembling the texture and consistency of natural penile tissue. This helps to maintain sexual wellness and aesthetic outcomes for both the patient and their partner, contributing to overall treatment success and patient acceptance.
   
• For instance, according to the National Institutes of Health, in 2023, there is 91% satisfaction rate for silicone based penile implants, thus leading to greater adoption.
   
• Silicone implants can be customized to match the individual anatomical characteristics and aesthetic preferences of the patient. Surgeons can tailor the size, shape, and contour of the implant to achieve optimal cosmetic and functional outcomes, ensuring a personalized approach to penile reconstruction and restoration of erectile function.
   
• Thus, such aforementioned factors are expected to augment the segmental growth.
   

Based on end-use, the penile implants market is segmented into hospitals, ambulatory surgical centres, and other end-users. The hospitals segment held a market share of 43.2% in 2023.
 

• Hospitals typically have specialized departments or units dedicated to urology, andrology, or sexual medicine, where experienced surgeons perform penile implant surgeries. These surgeons have the expertise and training to assess patients for candidacy, select the most appropriate implant type, and perform the implantation procedure with precision and skill, ensuring optimal outcomes for patients.
   
• Hospitals typically employ multidisciplinary care teams consisting of urologists, nurses, anesthesiologists, and other healthcare professionals who collaborate to provide comprehensive care to patients undergoing penile implant surgery. This team-based approach ensures coordinated preoperative evaluation, perioperative care, and postoperative management, optimizing patient outcomes and satisfaction.
   
• Hospitals have access to advanced medical technologies and diagnostic tools, such as imaging modalities (e.g., ultrasound, MRI) and laboratory tests, which are essential for preoperative assessment and planning in penile implant surgery. Additionally, hospitals may offer intraoperative tools and techniques, such as intraoperative penile doppler ultrasound, to aid in the precise placement of implants and optimize surgical outcomes. Thus, stimulating to the growth of the market.

U.S. penile implants market is set to grow at CAGR of 4.4% during 2024 and 2032.
 

• U.S. boasts a sophisticated healthcare infrastructure with renowned medical centers, hospitals, and specialty clinics equipped with state-of-the-art facilities, advanced medical technologies, and highly skilled healthcare professionals. This infrastructure enables the delivery of high-quality urological care, including penile implant surgery, to patients across the country.
   
• The increasing number of drunk driving in the U.S. serves as a significant driver for the penile implants market. For instance, according to the American Journal of Medicine, in 2023, erectile dysfunction affects over 18 million men in the US or 18.4% of the male population aged 20 years or older.
   

Germany penile implants industry is projected to witness lucrative growth between 2024 and 2032.
 

• Germany has a highly developed healthcare infrastructure with modern medical facilities, specialized clinics, and experienced healthcare professionals. The country's healthcare system is known for its high standards of quality, safety, and efficiency, providing access to advanced treatments and surgical procedures, including penile implants.
   
• The country is recognized for its strong focus on medical innovation and research in the field of healthcare. The country invests heavily in medical research, clinical trials, and technology development, leading to the advancement of medical devices and surgical techniques, including penile implants. This emphasis on innovation contributes to the availability of cutting-edge treatment options for patients with ED.
   

Japan penile implants market is expected to grow significantly over the years.
 

• Japan has one of the world's oldest populations, with a significant proportion of elderly individuals. As men age, they are more likely to experience erectile dysfunction (ED) due to factors such as age-related changes in hormonal levels, vascular health, and neurological function.
   
• The high prevalence of ED among older adults in Japan drives the demand for effective treatment options, including penile implants.
   

UAE penile implants market is anticipated to witness lucrative growth between 2024 to 2032.
 

• Erectile dysfunction is a common condition affecting men of all ages, including those in the UAE. Factors such as aging demographics, lifestyle changes, chronic diseases, and psychological stress contribute to the prevalence of ED in the population. As a result, there is a growing demand for effective treatment options, including penile implants, among men in the UAE.
   
• UAE has a culturally diverse population with a modern outlook on healthcare. There is generally a high level of acceptance of medical treatment and a willingness to seek help for health issues, including sexual dysfunction.
   

Penile Implants Market Share

The penile implants industry is highly competitive, marked by several players striving for market dominance. Providers offer implants with improved efficiency and affordability. This includes advancements in product, product design, material, and customization. Competition is driven by factors such as the quality, reliability, performance, cost, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.
 

Penile Implants Market Companies

Some of the eminent market participants operating in the penile implants industry include:

• Boston Scientific Corporation
• Coloplast Corp
• Dornier MedTech
• Eska Medical Gmbh
• Giant Medical LLC
• GT Urological, LLC
• Owen Mumford Ltd.
• Pos-T-Vac, Inc.
• Promedon
• Reflexonic LLC
• Rigicon Inc.
• Silimed
• Sofregen Medical Inc.
• Uroplasty Inc.
• Zephyr Surgical Implants
   

Penile Implants Industry News

• In April 2023, Coloplast introduced the Titan Penile Implant, a self-contained, fluid-filled system made from Bioflex and silicone. It is designed to emulate the look and performance of a natural erection, offering both standard and narrow-base cylinder styles. This product launch expanded the product portfolio of the company.
   
• In January 2020, Boston Scientific Corporation introduced Tactra, the next-generation malleable prosthesis. It was designed for enhanced ease of implant for physicians, and constructed for durability, offering patients both excellent rigidity and dependable concealment in a device that is natural to the touch. Thus, it enhanced the product landscape of the company and helped to generate the revenue.
   

This penile implants market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Implant Type

• Inflatable
• Non-inflatable

Market, By Material

• Silicone
• Bioflex
• Other materials

Market, By End-use

• Hospitals
• Ambulatory surgical centres
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa